Drug intelligence / Profile preview

CALCIOZ-K27

Development stage
Unknown
Lead developer
Chemross Lifesciences
Modality
Small Molecules
Administration
Oral
01

Overview

CALCIOZ-K27 is a combination nutritional supplement marketed by Chemross Lifesciences, primarily indicated for the management of bone-related disorders such as osteoporosis, osteomalacia, and calcium deficiency. The product is typically formulated as a softgel capsule containing Calcium (often as Calcium Citrate Maleate), Vitamin K2-7 (Menaquinone-7), and Vitamin D3 (Cholecalciferol). Calcium serves as a fundamental mineral for maintaining bone density and structural integrity. Vitamin D3 acts as a Vitamin D receptor agonist to enhance intestinal calcium absorption and regulate calcium homeostasis. Vitamin K2-7 serves as a critical cofactor for the enzyme gamma-glutamyl carboxylase, which activates osteocalcin, a protein essential for binding calcium to the bone matrix. This synergistic combination aims to improve bone mineralization while reducing the risk of ectopic vascular calcification.

Brand names
CALCIOZ-K27CALCIOZ-K-27CALCIOZ-K 27
02

Targets

GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)

Beyond the preview

Go deeper on CALCIOZ-K27.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CALCIOZ-K27.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call